Exhibition Review | Qankorey Shines at 2023 AAIC in Amsterdam
Visits:
2023-07-19
The Alzheimer's Association International Conference (AAIC) was held in grand style from 16-20 July, 2023 in Amsterdam, the Netherlands.
As the only Chinese enterprise participating in this international top summit, Qankorey displayed the world's first early dementia screening product with 3 PCT international patents-One Step Dementia Risk Test Kit, which attracted many overseas experts and scholars to stop and discuss frequently.
Professor Baijun Gu, Chief Scientist of Hunan Qankorey Biotechnology Co.,Ltd, one of the world's leading brain neuroscientists and a scholar of Australia's “Future Thousand Talents Programme”, was invited to attend this meeting and publish a research report.
Professor Colin Masters, a leading scientist in the global AD field and the founder of AIBL, the world's largest dementia research cohort, visited the booth of Qankorey and conducted in-depth academic discussions and exchanges with the scientific research team of Qankorey as well as Professor Lu Shen and Professor Bin Jiao from Xiangya Hospital of Central South University, and fully recognized and praised the scientific research direction and achievements of Qankorey!
The product will screen out people at high risk of early Alzheimer's disease by detecting the concentration level of amyloid β (Aβ), the earliest biomarker that appears in the course of Alzheimer's disease. The marker will not appear pathological changes until 17-23 years after deposition in the human body, and experts believe that the development of Alzheimer's disease can be effectively prevented and delayed through non-drug pathways at this stage.
The product adopts non-invasive sampling, urine detection, no need for professional medical operation, no need to use instruments, easy to operate, ten minutes of visual test results, affordable, can be used for rapid detection in medical institutions or home self-test.
The AAIC International Conference also released a number of report data, it is expected that by 2050, the number of dementia patients worldwide will triple to more than 152 million, while several counter-trends, such as the rise in smokers, high body mass index (BMI), and hyperglycaemia, are projected to increase the number of people living with the disease by 6.8 million, and a reduction of 6.2 million people living with dementia worldwide due to positive trends in global educational opportunities.
At present, overseas attention to Alzheimer's disease is gradually increasing, overseas markets also have a great space for development, this exhibition also laid the foundation for Qankorey in expanding overseas markets, through the market layout of this non-invasive self-test, convenient and fast early screening products, the global Alzheimer's disease early screening problem will be further solved.
RELATED INFORMATION
Domestic business consulting Tel:+86-731-85714218
E-mail:qankorey@qankorey.com
Internation Marketing Tel:+86-18874232226
E-mail:lisa@qankorey.com
Company address: 12F, Building 15, No.188 Middle Huanbao Road, Yuhua District, Changsha, Hunan, China 410116
Production Address: 4/F, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha,Hunan China,410007
Public Number
Small program
Jingdong
Taobao